Immunotherapy for high-grade glioma

scientific article published in May 2014

Immunotherapy for high-grade glioma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2217/FON.14.20
P698PubMed publication ID24941977

P2093author name stringSanjay Dixit
P2860cites workImmunotherapy coming of age: What will it take to make it standard of care for glioblastoma?Q34480557
Basic concepts of immunology and neuroimmunologyQ36525975
Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.Q55471514
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectimmunotherapyQ1427096
P304page(s)911-915
P577publication date2014-05-01
P1433published inFuture OncologyQ2781597
P1476titleImmunotherapy for high-grade glioma
P478volume10

Reverse relations

cites work (P2860)
Q52776751Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.
Q36705896Glioma-derived extracellular vesicles selectively suppress immune responses
Q47967336Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma
Q35741739Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma
Q26797282The progress of immunotherapy for glioblastoma
Q54942652Trends in Malignant Glioma Monoclonal Antibody Therapy.

Search more.